Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Researchers made two new compounds that could be used for medicine.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

New method makes important drug ingredients more easily without needing extra purification steps.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

A new patch can deliver stable antibodies over time for potential HIV treatment.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

34% of patients on hepatitis C treatment had reversible skin issues.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Some gonadal hormone drugs can block filovirus entry into cells.